导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -3.38% | 3116/4773 |
| 近一周 | -2.22% | 1525/5462 |
| 近一月 | -3.87% | 2035/5421 |
| 近一季 | -6.54% | 2130/5209 |
| 近半年 | -0.95% | 1434/4920 |
| 近一年 | -0.95% | 2804/4366 |
| 近两年 | 40.37% | 1876/2954 |
| 近三年 | 27.96% | 1141/2253 |
| 成立以来 | 537.96% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.41% 3830/4961 |
11.07% 2370/5312 |
- - |
- - |
| 2025 | 18.76% 2284/4813 |
-0.50% 2277/3635 |
2.52% 1516/4076 |
14.95% 2856/4524 |
1.28% 1435/4813 |
| 2024 | 20.12% 488/3463 |
4.22% 471/2808 |
-0.35% 742/3014 |
18.10% 1062/3129 |
-2.06% 1943/3463 |
| 2023 | -11.23% 1381/2656 |
0.64% 1718/2280 |
-2.98% 726/2385 |
-2.41% 673/2515 |
-6.85% 1943/2655 |
| 2022 | -20.27% 951/2207 |
-14.72% 991/1919 |
7.50% 462/2016 |
-13.30% 877/2113 |
0.32% 1507/2208 |
| 2021 | -3.62% 917/1822 |
-3.76% 825/1255 |
6.67% 728/1330 |
-8.91% 1161/1466 |
3.06% 481/1822 |
| 2020 | 42.64% 260/1250 |
-8.94% 641/1028 |
14.34% 558/1067 |
17.09% 119/1164 |
17.01% 141/1184 |
| 2019 | 41.30% 235/1092 |
26.95% 369/754 |
1.74% 112/804 |
3.26% 262/850 |
5.94% 665/918 |
| 2018 | -20.36% 192/834 |
- - |
- - |
- - |
-12.12% 403/691 |
| 2017 | 23.85% 128/714 |
- - |
- - |
- - |
- - |
| 2016 | -5.97% 188/605 |
- - |
- - |
- - |
- - |
| 2015 | -3.20% 272/575 |
- - |
- - |
- - |
- - |
| 2014 | 56.76% 47/237 |
- - |
- - |
- - |
- - |
| 2013 | -10.15% 154/186 |
- - |
- - |
- - |
- - |
| 2012 | 11.45% 33/140 |
- - |
- - |
- - |
- - |
| 2011 | -20.53% 40/102 |
- - |
- - |
- - |
- - |
| 2010 | -18.39% 49/58 |
- - |
- - |
- - |
- - |
| 2009 | 84.92% 13/27 |
- - |
- - |
- - |
- - |
| 2008 | -64.00% 20/26 |
- - |
- - |
- - |
- - |
| 2007 | 134.96% 14/22 |
- - |
- - |
- - |
- - |
| 2006 | 119.72% 10/14 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 融通巨潮100指数A(LOF) VS. 长安沪深300非周期A(740101) |